{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:07:43Z","timestamp":1789556863634,"version":"build-2803163510"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T00:00:00Z","timestamp":1683590400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:p>In this multisite, observational, matched cohort study of more than 80,000 pregnant people, receipt of an mRNA monovalent coronavirus disease 2019 (COVID-19) booster vaccination in pregnancy was not associated with increased risk for thrombocytopenia, myocarditis, venous thromboembolism, ischemic stroke, or other serious adverse events within 21 or 42 days after booster vaccination. The mRNA monovalent COVID-19 booster in pregnancy was associated with an increased risk for medically attended malaise or fatigue within 7 days of vaccination (adjusted rate ratio [aRR] 3.64, 95% CI 2.42\u20135.48) and lymphadenopathy or lymphadenitis within 21 days (aRR 3.25, 95% CI 1.67\u20136.30) or 42 days (aRR 2.18, 95% CI 1.33\u20133.58) of vaccination. Our findings are consistent with prior evaluations of the primary COVID-19 vaccine series and are reassuring with respect to COVID-19 booster vaccination in pregnancy.<\/jats:p>","DOI":"10.1097\/aog.0000000000005241","type":"journal-article","created":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T17:00:51Z","timestamp":1683824451000},"page":"125-129","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Medically Attended Acute Adverse Events in Pregnant People After Coronavirus Disease 2019 (COVID-19) Booster Vaccination"],"prefix":"10.1097","volume":"142","author":[{"given":"Malini B.","family":"DeSilva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Haapala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Vazquez-Benitez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas G.","family":"Boyce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candace C.","family":"Fuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew F.","family":"Daley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darios","family":"Getahun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon J.","family":"Hambidge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather S.","family":"Lipkind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison L.","family":"Naleway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer C.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly K.","family":"Vesco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric S.","family":"Weintraub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua T.B.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ousseny","family":"Zerbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elyse O.","family":"Kharbanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,5,9]]},"reference":[{"key":"R1-20260916","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0140-6736(22)02467-9","article-title":"Pregnancy outcomes and vaccine effectiveness during the period of omicron as the variant of concern, INTERCOVID-2022: a multinational, observational study","volume":"401","author":"Villar","year":"2023","journal-title":"Lancet"},{"key":"R2-20260916","doi-asserted-by":"crossref","first-page":"e2233273","DOI":"10.1001\/jamanetworkopen.2022.33273","article-title":"Estimation of COVID-19 mRNA vaccine effectiveness against medically attended COVID-19 in pregnancy during periods of Delta and Omicron variant predominance in the United States","volume":"5","author":"Schrag","year":"2022","journal-title":"JAMA Netw Open"},{"key":"R3-20260916","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1001\/jamainternmed.2022.2442","article-title":"Association of COVID-19 vaccination during pregnancy with incidence of SARS-CoV-2 infection in infants","volume":"182","author":"Carlsen","year":"2022","journal-title":"JAMA Intern Med"},{"key":"R4-20260916","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa2204399","article-title":"Maternal vaccination and risk of hospitalization for COVID-19 among infants","volume":"387","author":"Halasa","year":"2022","journal-title":"N Engl J Med"},{"key":"R5-20260916","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1001\/jama.2021.15494","article-title":"Spontaneous abortion following COVID-19 vaccination during pregnancy","volume":"326","author":"Kharbanda","year":"2021","journal-title":"JAMA"},{"key":"R6-20260916","doi-asserted-by":"crossref","first-page":"26","DOI":"10.15585\/mmwr.mm7101e1","article-title":"Receipt of COVID-19 vaccine during pregnancy and preterm or small-for-gestational-age at birth\u2014eight integrated health care organizations, United States, December 15, 2020-July 22, 2021","volume":"71","author":"Lipkind","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R7-20260916","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1056\/NEJMc2205276","article-title":"Evaluation of acute adverse events after COVID-19 vaccination during pregnancy","volume":"387","author":"DeSilva","year":"2022","journal-title":"N Engl J Med"},{"key":"R8-20260916","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1001\/jama.2022.4255","article-title":"Association of COVID-19 vaccination in pregnancy with adverse peripartum outcomes","volume":"327","author":"Fell","year":"2022","journal-title":"JAMA"},{"key":"R9-20260916","doi-asserted-by":"crossref","first-page":"e2230495","DOI":"10.1001\/jamanetworkopen.2022.30495","article-title":"Analysis of vaccine reactions after COVID-19 vaccine booster doses among pregnant and lactating individuals","volume":"5","author":"Kachikis","year":"2022","journal-title":"JAMA Netw Open"},{"key":"R10-20260916","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/AOG.0000000000004889","article-title":"Safety of booster doses of coronavirus disease 2019 (COVID-19) vaccine in pregnancy in the vaccine adverse event reporting system","volume":"140","author":"Moro","year":"2022","journal-title":"Obstet Gynecol"},{"key":"R11-20260916","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1001\/jama.2022.6834","article-title":"Receipt of COVID-19 booster dose among fully vaccinated pregnant individuals aged 18 to 49 years by key demographics","volume":"327","author":"Razzaghi","year":"2022","journal-title":"JAMA"},{"key":"R12-20260916","doi-asserted-by":"crossref","first-page":"204209862110212","DOI":"10.1177\/20420986211021233","article-title":"Vaccine Safety Datalink infrastructure enhancements for evaluating the safety of maternal vaccination","volume":"12","author":"Naleway","year":"2021","journal-title":"Ther Adv Drug Saf"},{"key":"R13-20260916","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.vaccine.2021.12.048","article-title":"Monitoring vaccine safety using the Vaccine Safety Datalink: assessing capacity to integrate data from Immunization Information systems","volume":"40","author":"Groom","year":"2022","journal-title":"Vaccine"},{"key":"R14-20260916","first-page":"331","article-title":"Software for optimal matching in observational studies","volume":"7","author":"Bergstralh","year":"1996","journal-title":"Epidemiology (Cambridge, MA)"},{"key":"R15-20260916","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1001\/jama.2021.15072","article-title":"Surveillance for adverse events after COVID-19 mRNA vaccination","volume":"326","author":"Klein","year":"2021","journal-title":"JAMA"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000005241","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:00:23Z","timestamp":1789556423000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000005241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,9]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000005241","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,9]]},"assertion":[{"value":"2023-03-22","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}